$ASTS
AST SpaceMobile, Inc.

2022 Q4 Form 10-K Financial Statement

#000095017023011124 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $0.00 $13.83M $12.41M
YoY Change -100.0% 11.45% 107.89%
Cost Of Revenue $0.00 $6.714M $7.563M
YoY Change -100.0% -11.23% 150.02%
Gross Profit $0.00 $7.111M $4.842M
YoY Change -100.0% 46.86% 64.58%
Gross Profit Margin 51.44% 39.03%
Selling, General & Admin $10.70M $48.33M $35.64M
YoY Change -7.82% 35.63% 189.25%
% of Gross Profit 679.68% 735.98%
Research & Development $30.66M $45.62M $23.44M
YoY Change 63.14% 94.62% 2218.5%
% of Gross Profit 641.54% 484.1%
Depreciation & Amortization $1.254M $4.711M $2.700M
YoY Change 45.14% 74.48% 285.71%
% of Gross Profit 66.25% 55.76%
Operating Expenses $42.61M $152.9M $91.59M
YoY Change 36.3% 66.92% 235.5%
Operating Profit -$42.61M -$145.8M -$86.75M
YoY Change 49.6% 68.04% 256.14%
Interest Expense $24.15M -$1.950M
YoY Change -1338.67% -2449.4%
% of Operating Profit
Other Income/Expense, Net $17.39M $43.27M $13.82M
YoY Change 9.11% 213.17% 16545.78%
Pretax Income -$25.22M -$102.5M -$72.93M
YoY Change 101.03% 40.54% 200.44%
Income Tax -$130.0K $617.0K $331.0K
% Of Pretax Income
Net Earnings -$8.229M -$31.64M -$73.26M
YoY Change 164.6% -56.81% 200.19%
Net Earnings / Revenue -228.86% -590.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.14 -$0.58 -$590.6K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.6M $238.6M $321.8M
YoY Change -25.86% -25.86% 321687.0%
Cash & Equivalents $238.6M $238.6M $321.8M
Short-Term Investments
Other Short-Term Assets $24.95M $29.72M $10.43M
YoY Change 414.52% 184.94% 10331.0%
Inventory $0.00 $0.00 $1.412M
Prepaid Expenses $4.100M
Receivables $0.00 $0.00 $2.173M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $268.3M $268.3M $335.8M
YoY Change -20.1% -20.1% 167801.5%
LONG-TERM ASSETS
Property, Plant & Equipment $146.0M $153.7M $103.9M
YoY Change 52.16% 47.85% 135.68%
Goodwill $0.00
YoY Change -100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.07M $16.40M $317.0K
YoY Change 97.47% 5074.13% 58.5%
Total Long-Term Assets $170.1M $170.1M $108.1M
YoY Change 57.27% 57.27% -53.43%
TOTAL ASSETS
Total Short-Term Assets $268.3M $268.3M $335.8M
Total Long-Term Assets $170.1M $170.1M $108.1M
Total Assets $438.4M $438.4M $443.9M
YoY Change -1.25% -1.25% 91.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.93M $13.93M $6.638M
YoY Change 109.84% 109.84% 1006.33%
Accrued Expenses $13.87M $6.398M $5.120M
YoY Change 71.13% 24.96% 46.29%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $242.0K
YoY Change
Total Short-Term Liabilities $27.80M $27.80M $21.38M
YoY Change 30.03% 30.03% 3462.83%
LONG-TERM LIABILITIES
Long-Term Debt $4.758M $4.758M $5.000M
YoY Change -4.84% -4.84%
Other Long-Term Liabilities $45.99M $45.99M $65.59M
YoY Change -29.88% -29.88% 709.72%
Total Long-Term Liabilities $4.758M $50.75M $70.59M
YoY Change -4.84% -28.1% 771.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.80M $27.80M $21.38M
Total Long-Term Liabilities $4.758M $50.75M $70.59M
Total Liabilities $78.55M $304.8M $343.7M
YoY Change -14.59% -11.3% 3850.08%
SHAREHOLDERS EQUITY
Retained Earnings -$102.1M
YoY Change 44.9%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $133.5M $133.5M $100.3M
YoY Change
Total Liabilities & Shareholders Equity $438.4M $438.4M $443.9M
YoY Change -1.25% -1.25% 91.02%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income -$8.229M -$31.64M -$73.26M
YoY Change 164.6% -56.81% 200.19%
Depreciation, Depletion And Amortization $1.254M $4.711M $2.700M
YoY Change 45.14% 74.48% 285.71%
Cash From Operating Activities -$35.04M -$156.5M -$80.10M
YoY Change 63.11% 95.35% 251.19%
INVESTING ACTIVITIES
Capital Expenditures $11.43M $30.32M $15.08M
YoY Change -179.97% 101.04% 85.65%
Acquisitions
YoY Change
Other Investing Activities -$104.0K $25.93M
YoY Change
Cash From Investing Activities -$11.54M -$31.35M -$54.79M
YoY Change -19.3% -42.78% 80.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $102.0M
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities 85.04M 102.3M 416.9M
YoY Change 134887.3% -75.45% 498.51%
NET CHANGE
Cash From Operating Activities -35.04M -156.5M -80.10M
Cash From Investing Activities -11.54M -31.35M -54.79M
Cash From Financing Activities 85.04M 102.3M 416.9M
Net Change In Cash 38.46M -85.28M 281.8M
YoY Change -207.69% -130.27% 1630.82%
FREE CASH FLOW
Cash From Operating Activities -$35.04M -$156.5M -$80.10M
Capital Expenditures $11.43M $30.32M $15.08M
Free Cash Flow -$46.47M -$186.8M -$95.18M
YoY Change 546.82% 96.25% 207.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001780312
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39040
CY2022 dei Entity Registrant Name
EntityRegistrantName
AST SPACEMOBILE, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2027232
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Midland Intl. Air & Space Port
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
2901 Enterprise Lane
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Midland
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
79706
CY2022 dei City Area Code
CityAreaCode
432
CY2022 dei Local Phone Number
LocalPhoneNumber
276-3966
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
258200000
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Miami, Florida
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238588000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
321787000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
668000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2750000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2173000
CY2022Q4 us-gaap Inventory Net
InventoryNet
0
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4100000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2831000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
24954000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4850000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
268310000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
335803000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
92077000
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
67615000
CY2022Q4 asts Property Plant And Equipment Net Excluded Construction In Progress
PropertyPlantAndEquipmentNetExcludedConstructionInProgress
53912000
CY2021Q4 asts Property Plant And Equipment Net Excluded Construction In Progress
PropertyPlantAndEquipmentNetExcludedConstructionInProgress
28327000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145989000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95942000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7671000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7991000
CY2022Q4 us-gaap Goodwill
Goodwill
0
CY2021Q4 us-gaap Goodwill
Goodwill
3641000
CY2022Q4 asts Other Non Current Assets
OtherNonCurrentAssets
16402000
CY2021Q4 asts Other Non Current Assets
OtherNonCurrentAssets
559000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24073000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12191000
CY2022Q4 us-gaap Assets
Assets
438372000
CY2021Q4 us-gaap Assets
Assets
443936000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13929000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6638000
CY2022Q4 asts Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
13145000
CY2021Q4 asts Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7469000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6636000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
722000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
634000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27796000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21377000
CY2022Q4 asts Warrant Liabilities
WarrantLiabilities
38946000
CY2021Q4 asts Warrant Liabilities
WarrantLiabilities
58062000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7046000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7525000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4758000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5000000
CY2022Q4 us-gaap Liabilities
Liabilities
78546000
CY2021Q4 us-gaap Liabilities
Liabilities
91964000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
235384000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
171155000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
229000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-433000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102101000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70461000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
226294000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
251693000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359826000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351972000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
438372000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
443936000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13825000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12405000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
6714000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
7563000
CY2022 us-gaap Gross Profit
GrossProfit
7111000
CY2021 us-gaap Gross Profit
GrossProfit
4842000
CY2022 us-gaap Other General Expense
OtherGeneralExpense
54212000
CY2021 us-gaap Other General Expense
OtherGeneralExpense
29599000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48332000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35636000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45620000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23440000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4711000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2913000
CY2022 us-gaap Operating Expenses
OperatingExpenses
152875000
CY2021 us-gaap Operating Expenses
OperatingExpenses
91588000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19114000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15766000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24154000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1950000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43268000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13816000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-102496000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72930000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
331000
CY2022 us-gaap Profit Loss
ProfitLoss
-103113000
CY2021 us-gaap Profit Loss
ProfitLoss
-73261000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-71473000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-42708000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-31640000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-30553000
CY2022 us-gaap Profit Loss
ProfitLoss
-103113000
CY2021 us-gaap Profit Loss
ProfitLoss
-73261000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-295000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-666000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-295000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-666000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-103408000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-73927000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-71704000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-43109000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31704000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30818000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351972000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9346000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
102769000
CY2022 asts Issuance Of Incentive Units Under Employee Stock Plan
IssuanceOfIncentiveUnitsUnderEmployeeStockPlan
73000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-417000
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
16000
CY2022 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
525000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-295000
CY2022 us-gaap Profit Loss
ProfitLoss
-103113000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359826000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79987000
CY2021 asts Stockbased Compensation Pre Business Combination
StockbasedCompensationPreBusinessCombination
370000
CY2021 asts Transaction Costs
TransactionCosts
45700000
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
342120000
CY2021 asts Stockbased Compensation Post Business Combination
StockbasedCompensationPostBusinessCombination
3404000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-666000
CY2021 us-gaap Profit Loss
ProfitLoss
-73261000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351972000
CY2022 us-gaap Profit Loss
ProfitLoss
-103113000
CY2021 us-gaap Profit Loss
ProfitLoss
-73261000
CY2022 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
24542000
CY2021 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
0
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4711000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2913000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19114000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15766000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-305000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2022 asts Noncash Lease Expense
NoncashLeaseExpense
720000
CY2021 asts Noncash Lease Expense
NoncashLeaseExpense
574000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
9391000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3736000
CY2022 asts Issuance Of Common Stock For Commitment Shares
IssuanceOfCommonStockForCommitmentShares
332000
CY2021 asts Issuance Of Common Stock For Commitment Shares
IssuanceOfCommonStockForCommitmentShares
0
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1993000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
220000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24588000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4216000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2461000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1039000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18438000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2091000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-680000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-398000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2395000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3572000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
16265000
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
159000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-156464000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80095000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30317000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15080000
CY2022 asts Payments For Constructions In Process
PaymentsForConstructionsInProcess
26967000
CY2021 asts Payments For Constructions In Process
PaymentsForConstructionsInProcess
39712000
CY2022 asts Proceeds From Sale Of Nano Net Of Cash Deconsolidated
ProceedsFromSaleOfNanoNetOfCashDeconsolidated
25932000
CY2021 asts Proceeds From Sale Of Nano Net Of Cash Deconsolidated
ProceedsFromSaleOfNanoNetOfCashDeconsolidated
0
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31352000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54792000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102023000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 asts Proceeds From Business Combination
ProceedsFromBusinessCombination
0
CY2021 asts Proceeds From Business Combination
ProceedsFromBusinessCombination
456420000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the audited </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on historical experience when available and on other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, useful lives assigned to property and equipment, the fair values of warrant liabilities, valuation and potential impairment of goodwill and long-lived assets, and equity-based compensation expense. The Company assesses estimates on an ongoing basis; however, actual results could materially differ from those estimates due to risks and uncertainties, including the continued uncertainty surrounding rapidly changing market and economic conditions due to the COVID-19 pandemic, geopolitical conflicts, and recent higher inflation and interest rates.</span></p>
CY2022 asts Direct And Incremental Costs Incurred For Business Combination
DirectAndIncrementalCostsIncurredForBusinessCombination
0
CY2021 asts Direct And Incremental Costs Incurred For Business Combination
DirectAndIncrementalCostsIncurredForBusinessCombination
39542000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
73000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
14000
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
230000
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
49000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
102340000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
416941000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
195000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-294000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-85281000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
281760000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
324537000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
239256000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
324537000
CY2022 asts Purchases Of Construction In Process In Accounts Payables And Accrued Expenses
PurchasesOfConstructionInProcessInAccountsPayablesAndAccruedExpenses
4670000
CY2021 asts Purchases Of Construction In Process In Accounts Payables And Accrued Expenses
PurchasesOfConstructionInProcessInAccountsPayablesAndAccruedExpenses
3265000
CY2022 asts Purchases Of Property And Equipment In Accounts Payable And Accrued Expense
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruedExpense
256000
CY2021 asts Purchases Of Property And Equipment In Accounts Payable And Accrued Expense
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruedExpense
1429000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1557000
CY2022 asts Purchases Of Property And Equipment Using Proceeds From Long Term Debt
PurchasesOfPropertyAndEquipmentUsingProceedsFromLongTermDebt
0
CY2021 asts Purchases Of Property And Equipment Using Proceeds From Long Term Debt
PurchasesOfPropertyAndEquipmentUsingProceedsFromLongTermDebt
5000000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
224000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
13000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
684000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
186000
CY2022 asts Nature Of Operations Description
NatureOfOperationsDescription
The Company operates from multiple locations that include its corporate headquarters and 185,000 square feet satellite assembly, integrating and testing (“AIT”) facilities in Texas, and AIT and engineering and development centers elsewhere in the United States, India, Scotland, Spain and Israel.
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
700000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
2800
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and trade receivables. The Company maintains its cash in accounts at financial institutions that the Company believes are of high credit quality. At times, the cash balance may exceed federally insured limits. The Company's foreign subsidiaries may deposit cash at institutions that are not insured by the FDIC. Cash and cash equivalents and restricted cash as of December 31, 2022 are subject to minimal credit risk.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s former subsidiary, Nano, accounted for all of the Company’s revenue for the years ended December 31, 2022 and 2021, and derived its revenue from customers located in various countries. Four customers accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Company’s revenue for the year ended December 31, 2022. Three customers accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Company’s revenue for the year ended December 31, 2021 and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Company’s trade receivables as of December 31, 2021. Prior to the sale of Nano, the Company managed credit risk and monitored its exposure to credit losses by reviewing the counterparties’ credit at least quarterly, and maintained allowances for credit losses and anticipated losses, if necessary. The Company’s methodology to measure the provision for credit losses considered all relevant information including information about historical collectability, current conditions and reasonable and supportable forecasts of future economic conditions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company did not record an allowance for credit losses for the year ended December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> due to the financial stability and creditworthiness of the Company's limited number of customers.</span></p>
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50% likelihood
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The shares of non-economic Class B and Class C Common Stock of the Company entitle each share to one vote and ten votes per share, respectively.
CY2022 us-gaap Minority Interest Description
MinorityInterestDescription
As a result of the Up-C structure, the noncontrolling interest is held by the Existing Equityholders who retained 71% of the economic ownership percentage of AST LLC.
CY2022Q4 asts Property Plant And Equipment Net Exculed Construction In Progress
PropertyPlantAndEquipmentNetExculedConstructionInProgress
53912000
CY2021Q4 asts Property Plant And Equipment Net Exculed Construction In Progress
PropertyPlantAndEquipmentNetExculedConstructionInProgress
28327000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
230651000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
314747000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
239300000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
324500000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
230700000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
314700000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
22947000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3073000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1673000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1580000
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
334000
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
197000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
24954000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4850000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14750000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
0
CY2022Q4 asts Other And Miscellaneous Noncurrent Assets
OtherAndMiscellaneousNoncurrentAssets
1652000
CY2021Q4 asts Other And Miscellaneous Noncurrent Assets
OtherAndMiscellaneousNoncurrentAssets
559000
CY2022Q4 asts Other Non Current Assets
OtherNonCurrentAssets
16402000
CY2021Q4 asts Other Non Current Assets
OtherNonCurrentAssets
559000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43474000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25218000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6979000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3592000
CY2022Q4 asts Property Plant And Equipment Satellite Materials
PropertyPlantAndEquipmentSatelliteMaterials
10721000
CY2021Q4 asts Property Plant And Equipment Satellite Materials
PropertyPlantAndEquipmentSatelliteMaterials
0
CY2022Q4 asts Property Plant And Equipment Construction In Progress
PropertyPlantAndEquipmentConstructionInProgress
92077000
CY2021Q4 asts Property Plant And Equipment Construction In Progress
PropertyPlantAndEquipmentConstructionInProgress
67615000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145989000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95942000
CY2022 us-gaap Depreciation
Depreciation
4600000
CY2021 us-gaap Depreciation
Depreciation
2700000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7671000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7991000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7768000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8159000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y8M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.131
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.134
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1191000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
440000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
939000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
563000
CY2022 us-gaap Lease Cost
LeaseCost
2130000
CY2021 us-gaap Lease Cost
LeaseCost
1003000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1632000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1543000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1546000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1563000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1348000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6011000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13643000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5875000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7768000
CY2022 asts Operating Lease Required Minimum Lease Payments
OperatingLeaseRequiredMinimumLeasePayments
9900000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
500000
CY2021Q4 us-gaap Goodwill
Goodwill
3641000
CY2020Q4 us-gaap Goodwill
Goodwill
3912000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-470000
CY2021 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-271000
CY2022 asts Deconsolidation Of Goodwill
DeconsolidationOfGoodwill
-3171000
CY2021 asts Deconsolidation Of Goodwill
DeconsolidationOfGoodwill
0
CY2022Q4 us-gaap Goodwill
Goodwill
0
CY2021Q4 us-gaap Goodwill
Goodwill
3641000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2357000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2983000
CY2022Q4 asts Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
3855000
CY2021Q4 asts Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1496000
CY2022Q4 asts Accrued Construction In Progress Current
AccruedConstructionInProgressCurrent
1796000
CY2021Q4 asts Accrued Construction In Progress Current
AccruedConstructionInProgressCurrent
1260000
CY2022Q4 asts Accrued Deferred Other Income
AccruedDeferredOtherIncome
2499000
CY2021Q4 asts Accrued Deferred Other Income
AccruedDeferredOtherIncome
0
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2638000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1730000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
13145000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7469000
CY2022Q4 asts Debt Instrument Carrying Amount For Total
DebtInstrumentCarryingAmountForTotal
5000000
CY2021Q4 asts Debt Instrument Carrying Amount For Total
DebtInstrumentCarryingAmountForTotal
5000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
242000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
4758000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
5000000
CY2021Q4 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2028-12-08
CY2021Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.0420
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0420
CY2022Q4 asts Estimated Fair Value Of Term Loan
EstimatedFairValueOfTermLoan
4300000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
242000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
252000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
263000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
274000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
286000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
3683000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5000000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13825000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12405000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
6636000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-2426000
CY2022 asts Increase Decrease In Contract Liability Excluding Revenue Recognized During Period
IncreaseDecreaseInContractLiabilityExcludingRevenueRecognizedDuringPeriod
3899000
CY2022 asts Revenue Recognized From Sale Of Former Subsidaiary
RevenueRecognizedFromSaleOfFormerSubsidaiary
-8109000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
If, and only if, the reported last sale price of the Class A Common Stock equals or exceeds $18.00
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
13800
CY2022Q4 asts Warrant Liabilities
WarrantLiabilities
38900000
CY2021Q4 asts Warrant Liabilities
WarrantLiabilities
58100000
CY2022 asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
19100000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
15800000
CY2022 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
49500000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9346000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3774000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12359322
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M1D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
87882197000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
667553
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
923970
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.37
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10767799
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M13D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42994264000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8122559
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.51
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M8D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
35027302000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
9388382
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.87
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M1D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
37040735000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5188990
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.64
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1798816
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.46
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
744934
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.51
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2645240
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.80
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.15
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3100000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
10.00
CY2021Q4 asts Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairMarketValue
4.15
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4224
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0055
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
Two types of equity awards have been granted under the 2020 Plan: (1) service-based options and (2) service-based and performance-based restricted stock units. Service-based options typically vest over a four year service period with 25% of the award vesting on the first anniversary of the employee’s commencement date, and the balance thereafter in 36 equal monthly installments. Service-based restricted stock units typically vest over a four year service period with 25% of the award vesting on each anniversary of the employee’s vesting commencement date. Performance-based restricted stock units typically vest on the earliest date that any of the following occurs: (i) the Company attains an incremental capital investment, or (ii) other specified performance conditions. Options typically expire no later than 10 years from the date of grant.
CY2022Q3 asts Percent Of Subsidiary Interest Sold
PercentOfSubsidiaryInterestSold
0.51
CY2022Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
65000000.0
CY2022Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
26600000
CY2022Q3 asts Carrying Value Of Assets
CarryingValueOfAssets
17600000
CY2022Q3 asts Carrying Value Of Liabilities
CarryingValueOfLiabilities
15100000
CY2022Q3 asts Carrying Value Of Noncontrolling Interest
CarryingValueOfNoncontrollingInterest
1300000
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
24500000
CY2022 asts Reclassification Of Accumulated Translation Adjustments
ReclassificationOfAccumulatedTranslationAdjustments
-700000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-98774000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-70396000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3722000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2534000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-102496000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72930000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
617000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
331000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
617000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
331000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
331000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.16
CY2021 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.19
CY2022 asts Effective Income Tax Rate Reconciliation Changes In Fair Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangesInFairValueOfWarrantLiabilities
0.04
CY2021 asts Effective Income Tax Rate Reconciliation Changes In Fair Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangesInFairValueOfWarrantLiabilities
0.05
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.10
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.99
CY2022 asts Business Combination Expenses
BusinessCombinationExpenses
0
CY2021 asts Business Combination Expenses
BusinessCombinationExpenses
0.89
CY2022 asts Effective Income Tax Rate Reconciliation Research And Development Credit
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCredit
0.02
CY2021 asts Effective Income Tax Rate Reconciliation Research And Development Credit
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCredit
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.02
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.03
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11788000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8212000
CY2022Q4 asts Deferred Tax Assets Basis Difference In The Equity Of Ast Llc
DeferredTaxAssetsBasisDifferenceInTheEquityOfAstLlc
79396000
CY2021Q4 asts Deferred Tax Assets Basis Difference In The Equity Of Ast Llc
DeferredTaxAssetsBasisDifferenceInTheEquityOfAstLlc
62717000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3680000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1495000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
94864000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
72425000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94864000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
72425000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 asts Net Operating Loss Carryforwards Expiration Year
NetOperatingLossCarryforwardsExpirationYear
2041
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
72400000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Profit Loss
ProfitLoss
-103113000
CY2021 us-gaap Profit Loss
ProfitLoss
-73261000
CY2022 asts Net Income Loss Attributable To Business Combination
NetIncomeLossAttributableToBusinessCombination
0
CY2021 asts Net Income Loss Attributable To Business Combination
NetIncomeLossAttributableToBusinessCombination
11580000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-71473000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-42708000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31640000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-31640000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18973000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18973000
CY2022Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.07
CY2022Q1 asts Consolidated Cash Exceeds
ConsolidatedCashExceeds
4000000.0
CY2022Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
500000
CY2022 us-gaap Related Party Costs
RelatedPartyCosts
100000
CY2021 us-gaap Related Party Costs
RelatedPartyCosts
300000
CY2020Q1 asts Maintenance Fee Payable
MaintenanceFeePayable
500000

Files In Submission

Name View Source Status
0000950170-23-011124-index-headers.html Edgar Link pending
0000950170-23-011124-index.html Edgar Link pending
0000950170-23-011124.txt Edgar Link pending
0000950170-23-011124-xbrl.zip Edgar Link pending
asts-20221231.htm Edgar Link pending
asts-20221231.xsd Edgar Link pending
asts-ex21_1.htm Edgar Link pending
asts-ex23_1.htm Edgar Link pending
asts-ex31_1.htm Edgar Link pending
asts-ex31_2.htm Edgar Link pending
asts-ex32_1.htm Edgar Link pending
asts-ex32_2.htm Edgar Link pending
asts-ex4_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
asts-20221231_lab.xml Edgar Link unprocessable
asts-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
asts-20221231_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
asts-20221231_cal.xml Edgar Link unprocessable
asts-20221231_def.xml Edgar Link unprocessable